Bulletin

Roche

Early treatment with Roche's OCREVUS leads to reduced disease progression and healthcare costs; nine-year safety data reinforce favourable benefit-risk profile

October 26, 2023

WHO

WHO calls for immediate release, access to, and medical support for hostages taken by Hamas

October 25, 2023

WHO

Shock, grief and the challenge of healing: Israel’s health system responds to the October attacks

October 24, 2023

Roche

Roche’s Alecensa reduces the risk of disease recurrence or death by an unprecedented 76% in people with ALK-positive early-stage non-small cell lung cancer

October 18, 2023

Roche

Roche IL-6 is the first immunoassay approved to aid sepsis diagnosis in newborns

October 18, 2023

WHO

UNICEF and WHO warn that further attacks and disruptions of health and nutrition services in Sudan could cost over 10 000 young lives by the end of 2023

October 18, 2023

Press Information Bureau

Union Health Secretary Shri Sudhansh Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface” & National Conclave for Endorsement of “National Action Plan for Prevention and Control of Snakebite Envenoming” to Stakeholders

October 17, 2023

Roche

Roche’s OCREVUS twice-yearly, 10-minute subcutaneous injection was non-inferior to intravenous infusion and provided near-complete suppression of brain lesions

October 16, 2023

WHO

Lifesaving WHO health supplies land in Egypt for people-in-need in Gaza

October 14, 2023

WHO

Lifesaving WHO health supplies land in Egypt for people-in-need in Gaza

October 14, 2023

Roche

Late-breaking data for Roche’s BTK inhibitor fenebrutinib show brain penetration and significant reduction in lesions in patients with relapsing multiple sclerosis

October 13, 2023

WHO

New funding to ensure 370 million children receive polio vaccinations and to boost health innovation in low-income countries

October 11, 2023

WHO

New funding to ensure 370 million children receive polio vaccinations and to boost health innovation in low-income countries

October 11, 2023

WHO

WHO works to strengthen mental health services in Libya in the aftermath of Storm Daniel

October 10, 2023

WHO

Five key themes for improved mental health care for refugees and migrants

October 10, 2023

Roche

Roche’s Vabysmo maintained vision improvements with extended treatment intervals up to four months for people with retinal vein occlusion (RVO) in phase III studies

October 10, 2023

< 1 … 34 35 36 37 38 39 40 41 42 … 94 >

Maker Towers 63 A ,Cuffe Parade South Mumbai Maharashtra Pin Code 400005

About Us Advisory Board Profile

Announcements Featured Story Highlights Bulletin

Interview Guest Desk Viewpoint

Bulletin

Early treatment with Roche's OCREVUS leads to reduced disease progression and healthcare costs; nine-year safety data reinforce favourable benefit-risk profile

WHO calls for immediate release, access to, and medical support for hostages taken by Hamas

Shock, grief and the challenge of healing: Israel’s health system responds to the October attacks

Roche’s Alecensa reduces the risk of disease recurrence or death by an unprecedented 76% in people with ALK-positive early-stage non-small cell lung cancer

Roche IL-6 is the first immunoassay approved to aid sepsis diagnosis in newborns

UNICEF and WHO warn that further attacks and disruptions of health and nutrition services in Sudan could cost over 10 000 young lives by the end of 2023

Roche’s OCREVUS twice-yearly, 10-minute subcutaneous injection was non-inferior to intravenous infusion and provided near-complete suppression of brain lesions

Lifesaving WHO health supplies land in Egypt for people-in-need in Gaza

Lifesaving WHO health supplies land in Egypt for people-in-need in Gaza

Late-breaking data for Roche’s BTK inhibitor fenebrutinib show brain penetration and significant reduction in lesions in patients with relapsing multiple sclerosis

New funding to ensure 370 million children receive polio vaccinations and to boost health innovation in low-income countries

New funding to ensure 370 million children receive polio vaccinations and to boost health innovation in low-income countries

WHO works to strengthen mental health services in Libya in the aftermath of Storm Daniel

Five key themes for improved mental health care for refugees and migrants

Roche’s Vabysmo maintained vision improvements with extended treatment intervals up to four months for people with retinal vein occlusion (RVO) in phase III studies

Company

Resources